Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 04, 2017 08:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Presents Preclinical Data Demonstrating Multiple Therapeutic Advantages from BCMA-Specific CAR-T Program at American Association for Cancer Research Annual Meeting

SAN DIEGO, April 04, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...
January 03, 2017 09:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Appoints Debra Gessner as Vice President, Regulatory Affairs

SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today announced...
December 05, 2016 13:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Presents Preclinical Data Demonstrating Tumor Response from BCMA-Specific CAR-T Program at American Society of Hematology Annual Meeting

SAN DIEGO, Dec. 05, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...
November 03, 2016 09:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics to Present Three Abstracts on Novel BCMA-Specific CAR-T Therapy at American Society of Hematology 2016 Annual Meeting

SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...
September 08, 2016 07:30 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Establishes Scientific Advisory Board

SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics,...
August 18, 2016 07:30 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Expands Executive Leadership Team

SAN DIEGO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics,...
December 16, 2015 09:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Announces Series A Financing

LA JOLLA, Calif., Dec. 16, 2015 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a US-based, privately-held, human therapeutics company focused on the development of novel therapies using...
August 11, 2015 06:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc. Announces Worldwide License Agreement With Janssen to Apply Centyrin Technology in the Development of Chimeric Antigen Receptor (CAR) Therapies

SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (Poseida), a private biotechnology company spun out of Transposagen Biopharmaceuticals, Inc. (Transposagen), and headquartered...
August 05, 2015 16:27 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc., Expands Board of Directors

SAN DIEGO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (Poseida), a privately-held human therapeutics spinout of Transposagen Biopharmaceuticals, Inc. (Transposagen), announces the...
June 01, 2015 11:15 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics to Participate in Jefferies 2015 Healthcare Conference

SAN DIEGO, June 1, 2015 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. ("Poseida"), a privately-held human therapeutics spinout of Transposagen Biopharmaceuticals, Inc. ("Transposagen"), announces...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right